Chemical Compound

efavirenz

CAS Registry Number 154598-52-4
Back to search Request a Quote
efavirenz chemical structure
Primary Record

efavirenz

In stock
9,805 g
Purity
98.4 %
CAS
154598-52-4

Compound Identifiers & Properties

CAS
154598-52-4
PubChem CID
64139
SMILES
C1CC1C#C[C@]2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
Canonical SMILES
O=C1Nc2ccc(Cl)cc2[C@@](C#CC2CC2)(C(F)(F)F)O1

Names & Synonyms

  • efavirenz
  • Sustiva
  • Stocrin
  • 154598-52-4
  • Viraday
  • Efavirenz teva
  • (-)-Efavirenz
  • DMP-266
  • Efavirenzum
  • Eravirenz
  • (S)-Efavirenz
  • (Rac)-Efavirenz
  • ent Efavirenz
  • Efavirenz RS
  • Strocin (TM)
  • Sustiva (TM)
  • Sustiva (TN)
  • zoxazin-2-one
  • 1ikv
  • 1ikw
  • Efavirenz, (S)
  • Atripla (TN)
  • Stocrin (TN)
  • Efavirenz & PLGA
  • efavirenz, (S)-
  • DMP 266
  • efavirenz, (S)-isomer
  • GUANFACINE
  • Sustiva 600
  • Efavirenz (Standard)
  • Efavirenz & IFNL1
  • Efavirenz & IFNL2
  • Efavirenz & IFNL3
  • C14H9ClF3NO2
  • Efavirenz & IL-29
  • Efavirenz (JAN/INN)
  • Efavirenz [INN:BAN]
  • EFAVIRENZ [INN]
  • EFAVIRENZ [JAN]
  • DMP-266; Efavirenz
  • Efavirenz & IL-28A
  • Efavirenz & IL-28B
  • EFAVIRENZ [MI]
  • EFAVIRENZ [HSDB]
  • EFAVIRENZ [USAN]
  • EFV & Interleukin 29
  • RefChem:590606
  • Efavirenz [USP:INN:BAN]
  • EFAVIRENZ [VANDF]
  • JE6H2O27P8
  • UNII-JE6H2O27P8
  • EFV & Interleukin 28A
  • EFV & Interleukin 28B
  • EFV & PLGA
  • DTXSID9046029
  • D07HVY
  • EFAVIRENZ [MART.]
  • Epitope ID:231718
  • HSDB 7163
  • AC1L20IX
  • EFAVIRENZ [USP-RS]
  • EFAVIRENZ [WHO-DD]
  • EFAVIRENZ [WHO-IP]
  • EFV & IFNL1
  • EFV & IFNL2
  • EFV & IFNL3
  • CHEBI:119486
  • DMP266
  • XPOQHMRABVBWPR-ZDUSSCGKSA-N
  • Efavirenz (JAN/USP/INN)
  • EFV & Interferon lambda-1
  • EFV & Interferon lambda-2
  • EFV & Interferon lambda-3
  • Efavirenz & Interleukin 29
  • Met-SDF-1.beta. & Efavirenz
  • MFCD05662344
  • SCHEMBL37762
  • DTXCID7026029
  • EFAVIRENZ [EMA EPAR]
  • Efavirenz & Interleukin 28A
  • Efavirenz & Interleukin 28B
  • Efavirenz Ready Made Solution
  • MLS000759465
  • MLS001424087
  • TELURA COMPONENT EFAVIRENZ
  • BIDD:GT0383
  • NSC-742403
  • Efavirenz - Bio-X trade mark
  • AMY229
  • BDBM2483
  • CHEMBL223228
  • EFV & IL-28A
  • EFV & IL-28B
  • orb1305550
  • EFAVIRENZ [ORANGE BOOK]
  • Efavirenz, >=98% (HPLC)
  • CTK8E9137
  • Efavirenz & Interferon lambda-1
  • Efavirenz & Interferon lambda-2
  • Efavirenz & Interferon lambda-3
  • EFV & IL-29
  • GTPL11287
  • KS-00000ZEH
  • KS-00002WWM
  • AOB2950
  • EFAVIRENZ [USP MONOGRAPH]
  • J05AG03
  • L-743726
  • ATRIPLA COMPONENT EFAVIRENZ
  • NSC742403
  • BCPP000245
  • C14-H9-Cl-F3-N-O2
  • GLXC-04867
  • HMS2051J08
  • HMS2090N16
  • HMS3393J08
  • HMS3713M14
  • EFAVIRENZUM [WHO-IP LATIN]
  • (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
  • ALBB-038626
  • BCP27719
  • CID64139
  • EFV
  • MSK10874
  • ZINC2020233
  • (4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
  • (4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
  • L-743,726
  • Tox21_111582
  • DL-535
  • EBC-12705
  • HY-10572R
  • s4685
  • AKOS015894951
  • Efavirenz & Poly-lactide-co-glycolide
  • Tox21_111582_1
  • AB21723
  • ACN-029242
  • BCP9000636
  • CB11317
  • CCG-101011
  • CS-2154
  • DB00625
  • EFAVIRENZ 200MG SCORED TABLETS
  • FC30275
  • KS-5380
  • MK-0831
  • NC00261
  • NSC 742403
  • RL01986
  • RTX-012332
  • L 743726
  • Efavirenz 100 microg/mL in Acetonitrile
  • NCGC00159337-02
  • NCGC00159337-04
  • NCGC00159337-12
  • NCGC00271713-05
  • NCGC00271713-08
  • AC-25006
  • AK323634
  • BC164402
  • BC214923
  • CJ-31514
  • CPD000466351
  • HY-10572
  • SAM001246667
  • SC-46515
  • SMR000466351
  • SY009682
  • J727.577C
  • LS-173464
  • (S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
  • B1119
  • CAS-154598-52-4
  • E0997
  • NS00000604
  • (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one
  • C08088
  • D00896
  • EN300-219935
  • F17329
  • L 741211
  • L-741211
  • L-743725
  • AB00639956-06
  • AB00639956-08
  • (-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE
  • (4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
  • (Rac)-DMP 266; (Rac)-EFV; (Rac)-L-743726
  • (S)-6-CHLORO-4-(CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE
  • 598E524
  • A809555
  • L741211
  • L743726
  • Q422645
  • SR-01000759360
  • A1200834
  • SR-01000759360-4
  • SR-01000759360-5
  • BRD-K40758068-001-08-2
  • L 743,726
  • Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz
  • 177530-93-7
  • Z2177953192
  • (S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
  • 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-
  • 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one
  • Efavirenz, United States Pharmacopeia (USP) Reference Standard
  • EFZ
  • (4S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one
  • (s)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
  • (S)-6-Chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one
  • (S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one
  • Efavirenz solution, 1.0 mg/mL in acetonitrile, certified reference material
  • (4S)-6-chloranyl-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
  • (S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-ben
  • (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo(d)(1,3)oxazin-2-one
  • 2H-3, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-
  • 2h-3,1-benzoxazin-2-ona, 6-cloro-4-(2-ciclopropiletinil)-1,4-dihidro-4-(trifluorometil)-
  • 6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-3-one
  • 6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
  • (4S)-4-(Cyclopropylethynyl)-4-(trifluoromethyl)-6-chloro-1,4-dihydro-2H-3,1-benzoxazin-2-one
  • (4S)-4alpha-(Trifluoromethyl)-4-(cyclopropylethynyl)-6-chloro-1,2-dihydro-4H-3,1-benzoxazin-2-one
  • (4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (4S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; (-)-Efavirenz; (S)-4-(2-Cyclopropylethynyl)-6-chloro-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one; (S)-4-(Cyclopropylethynyl)-6-chloro-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one; (S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one; DMP 266; EFV; Efavirenz; L 743726; Stocrin; Sustiva
  • (4S)-6-Chloro-4alpha-(trifluoromethyl)-4-(cyclopropylethynyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
  • (S)-6-Chloro-4-(cyclopropyl-ethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazine-2-one
  • (S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-(S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
  • (S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-ben zoxazin-2-one
  • (S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
  • 2h-3,1-benzoxazin-2-ona, 6-cloro-4-(2-ciclopropiletinil)-1,4-dihidro-4-(trifluorometil)-, (4s)-
  • 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-
  • 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-(9
  • 6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo(d)(1,3)oxazin-2-one